First Patient Cases Performed with Remanufactured da Vinci Xi Instruments
FDA clearance enables reuse of da Vinci Xi instruments, offering hospitals a new sourcing option.
FDA clearance enables reuse of da Vinci Xi instruments, offering hospitals a new sourcing option.
Clarivate’s “Medical Technologies to Watch in 2024” report highlights five high-growth med-tech innovations: pulsed field ablation devices, diabetes care devices, neurostimulation devices, surgical robotics, and renal denervation, poised to generate significant clinical and commercial value.
The FDA has cleared Zeta Surgical's Zeta Cranial Navigation System mixed reality surgical navigation system.
FDA clearance enables reuse of da Vinci Xi instruments, offering hospitals a new sourcing option.
Levita Magnetics announced the closing of its $26 million Series C financing for its Magnetic-Assisted Robotic Surgery (MARS) platform.
Read MoreMedical Microinstruments, a robotics company improving clinical outcomes for patients undergoing microsurgery, raised $75 million.
Read MoreAccelus combined its Remi Robotic Navigation, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device technologies.
Read MoreVirtual Incision’s robotic-assisted surgery platform received Investigational Device Exemption approval from the FDA.
Read MoreCentennial Hills Hospital is the first facility in the western U.S. to utilize the latest iteration of THINK Surgical’s TSolution One robot.
Read MoreThe cybersecurity contracts include manufacturers of surgical robotics technologies and virtual reality applications for minimally invasive surgery.
Read MoreThe robotic prostatectomy using Medtronic’s Hugo robotic-assisted surgery (RAS) system was performed at a Belgium-based hospital.